Cost-Effectiveness Of Denosumab In The Treatment Of Postmenopausal Osteoporosis (Pmo) Women In Mexico At High Risk Of Fractures And Intolerant To Oral Bisphosphonates
May 1, 2013, 00:00
10.1016/j.jval.2013.03.1141
https://www.valueinhealthjournal.com/article/S1098-3015(13)01212-6/fulltext
Title :
Cost-Effectiveness Of Denosumab In The Treatment Of Postmenopausal Osteoporosis (Pmo) Women In Mexico At High Risk Of Fractures And Intolerant To Oral Bisphosphonates
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)01212-6&doi=10.1016/j.jval.2013.03.1141
First page :
A225
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
716